Markets:

Overview

News

Currencies

International

Treasuries

Organon & Co. Common Stock (NY:OGN)

8.050 -0.080 (-0.98%)

Official Closing Price Updated: 7:00 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Organon & Co. Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Johnson & Johnson Pops As It Announces The Biggest Split In Health Care ↗

November 12, 2021

Johnson & Johnson will split its consumer health unit into a publicly traded company.

Via Investor's Business Daily

Veteran's Day ↗

November 11, 2021

Stock markets took a tumble today across the board, but not as far down as at the opening.

Via Talk Markets

Lower Sales Impact Organon's Q3 Margins; Acquires Forendo Pharma For Over $900M ↗

November 11, 2021

Organon & Co (NYSE: OGN) has reported Q3 sales of $1.6 billion, down 1% Y/Y, slightly higher than the consensus of $1.58 billion. Women's Health declined...

Via Benzinga

Organon Beat Quarterly Forecasts, Unveiled Takeover — Here's Why Shares Fell ↗

November 11, 2021

Organon topped forecasts on Thursday and announced its plan to buy Forendo Pharma.

Via Investor's Business Daily

Organon Reports Results for the Third Quarter Ended September 30, 2021

November 11, 2021

From Organon & Co.

Via Business Wire

Earnings Scheduled For November 11, 2021 ↗

November 11, 2021

Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape...

Via Benzinga

Expert Ratings For Organon ↗

October 07, 2021

Analysts have provided the following ratings for Organon (NYSE:OGN) within th...

Via Benzinga

What 6 Analyst Ratings Have To Say About Organon ↗

September 01, 2021

Organon (NYSE:OGN) has observed the following analyst ratings within the last...

Via Benzinga

Organon to Acquire Forendo Pharma

November 11, 2021

From Organon & Co.

Via Business Wire

Why Merck's Strong Outlook For 2021 Could Become Even More Bullish ↗

October 28, 2021

Merck issued upbeat guidance for 2021 that could grow if Covid pill molnupiravir gains authorization.

Via Investor's Business Daily

Organon To Report Third Quarter Results and Host Conference Call on November 11, 2021

October 28, 2021

From Organon & Co.

Via Business Wire

Europe's Unicorns ↗

October 15, 2021

After markets jumped yesterday, we saw a lot of bounce today although gold fell back a bit.

Via Talk Markets

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Unusual Options Activity Insight: UP Fintech Holding ↗

July 30, 2021

Organon (NYSE:OGN) shares experienced unusual options activi...

Via Benzinga

Organon Launches New Fertility Journey Website as Part of Ongoing Commitment to Help Address the Needs of Women

October 15, 2021

From Organon & Co.

Via Business Wire

Organon Receives FDA Clearance for Technological Updates to the Jada® System, a Medical Device Intended to Control Postpartum Hemorrhage

October 11, 2021

From Organon & Co.

Via Business Wire

Organon Aims to Ignite Worldwide Conversation Around Unplanned Pregnancy

September 21, 2021

From Organon & Co.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021 ↗

October 07, 2021

Upgrades For State Street Corporation (NYSE:

Via Benzinga

Organon To Present at Morgan Stanley’s 19th Annual Global Healthcare Virtual Conference

September 01, 2021

From Organon & Co.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2021 ↗

September 01, 2021

Upgrades For Chatham Lodging Trust (NYSE:

Via Benzinga

Organon To Present at Citi’s 16th Annual BioPharma Virtual Conference

September 01, 2021

From Organon & Co.

Via Business Wire

Top Stocks Warren Buffett Just Bought ↗

August 18, 2021

These were Berkshire Hathaway's biggest buys during Q2, 2021.

Via The Motley Fool

Q2 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios ↗

August 17, 2021

The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and...

Via Benzinga

Friday the Thirteenth ↗

August 13, 2021

The stock week in points eastward was mixed. The USA markets face a bear correction.

Via Talk Markets

Merck Spinoff Organon Just Reported Its First Quarter — Here's What You Need To Know ↗

August 12, 2021

Organon crushed Wall Street's second-quarter expectations on Thursday and announced its first dividend, leading OGN stock to pop.

Via Investor's Business Daily

Organon Reports Results for the Second Quarter Ended June 30, 2021 and Announces Inaugural Dividend

August 12, 2021

From Organon & Co.

Via Business Wire

ObsEva Stock Surges On Potential $500M Ebopiprant Deal For Preterm Labor ↗

July 27, 2021

Organon & Co (NYSE: OGN) will license the global development, manufacturing, and commercial rights to ObsEva SA's (NASDAQ: OBSV) ebopiprant (OBE022)...

Via Benzinga

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗

August 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...

Via Benzinga

Earnings Scheduled For August 12, 2021 ↗

August 12, 2021

Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS...

Via Benzinga

The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts ↗

July 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.